204 related articles for article (PubMed ID: 3469017)
1. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
Bhalla K; Hindenburg A; Taub RN; Grant S
Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
Bogush T; Robert J
Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
[TBL] [Abstract][Full Text] [Related]
4. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
Hu X; Chen WY
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):275-9. PubMed ID: 7976387
[TBL] [Abstract][Full Text] [Related]
5. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
[TBL] [Abstract][Full Text] [Related]
6. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.
Hindenburg AA; Gervasoni JE; Krishna S; Stewart VJ; Rosado M; Lutzky J; Bhalla K; Baker MA; Taub RN
Cancer Res; 1989 Aug; 49(16):4607-14. PubMed ID: 2545346
[TBL] [Abstract][Full Text] [Related]
7. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
8. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
Tsuruo T
Cancer Treat Rep; 1983 Oct; 67(10):889-94. PubMed ID: 6354436
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacology of anthracycline resistance and its circumvention.
Tapiero H; Fourcade A; Munck JN; Zwingelstein G; Lampidis TJ
Drugs Exp Clin Res; 1986; 12(1-3):265-73. PubMed ID: 3460753
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
Sweet P; Chan PK; Slater LM
Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug.
Marsh W; Sicheri D; Center MS
Cancer Res; 1986 Aug; 46(8):4053-7. PubMed ID: 2425939
[TBL] [Abstract][Full Text] [Related]
13. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.
Klohs WD; Steinkampf RW
Mol Pharmacol; 1988 Aug; 34(2):180-5. PubMed ID: 2901030
[TBL] [Abstract][Full Text] [Related]
14. Biochemical mechanism for resistance to anthracycline antibiotics.
Inaba M
Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
[No Abstract] [Full Text] [Related]
15. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
Schwartz HS; Kanter PM
Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
[TBL] [Abstract][Full Text] [Related]
17. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies on anthracycline haloderivatives.
Facchinetti T; Geroni C; Fumagalli A; Giuliani FC
Drugs Exp Clin Res; 1986; 12(8):657-61. PubMed ID: 3463498
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
20. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
